Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 1
1997 1
2000 3
2015 2
2017 1
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for sayed mk[au]
Your search for Ayed MK[au] retrieved no results
Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-analysis.
Nourelden AZ, Elshanbary AA, El-Sherif L, Benmelouka AY, Rohim HI, Helmy SK, Sayed MK, Ismail A, Ali AS, Ragab KM, Zaazouee MS. Nourelden AZ, et al. Among authors: sayed mk. Endocr Metab Immune Disord Drug Targets. 2020 Dec 9. doi: 10.2174/1871530320999201209222921. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 33302842
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page